scholarly journals Montreal Cognitive Assessment Delayed Recall Test

2020 ◽  
Author(s):  
Keyword(s):  
Cognitive Assessment ◽  
Recall Test ◽  
Montreal Cognitive Assessment ◽  
Delayed Recall

scholarly journals The effect of vitamin D on cognitive functions in young female patients: a prospective controlled study using the Montreal Cognitive Assessment

2019 ◽  
Vol 77 (1) ◽  
pp. 19-24
Author(s):  
Ozlem Balbaloglu ◽  
Nermin Tanık
Keyword(s):  
Vitamin D ◽  
Cognitive Functioning ◽  
Cognitive Assessment ◽  
Young Female ◽  
Montreal Cognitive Assessment ◽  
Controlled Study ◽  
Delayed Recall ◽  
Female Patients ◽  
Vitamin D Levels ◽  
Before And After

ABSTRACT Aim: Our aim was to determine whether there is a relationship between vitamin D [25(OH)D] and cognitive functioning in women with low 25(OH)D levels. Methods: Ninety female patients, 25-45 years of age, who attended our outpatient clinic and had 25(OH)D levels < 30 ng/mL, were included. The Montreal Cognitive Assessment (MoCA) scale was used to determine cognitive functioning; the scale is divided into seven subgroups. Patients were divided into three subgroups according to their 25(OH)D levels. After a three-month period of 25(OH) D replacement, the patients underwent a re-evaluation using the MoCA scale. Results: The total MoCA score before treatment was significantly different from the score after treatment (p < 0.05). Language and delayed recall functions were significantly different before and after treatment (p < 0.05). Conclusion: Vitamin D levels were related to cognitive functioning in our study group.

scholarly journals Memory Performance in Patient with Systemic Lupus Erythematosus Using MoCA-Ina in Hasan Sadikin Genneral Hospital Bandung

2018 ◽  
Vol 9 (1) ◽  
Author(s):  
Safira Anjalia ◽  
Paulus Anam Ong ◽  
Nur Atik ◽  
Laniyati Hamijoyo
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Cognitive Impairment ◽  
Lupus Erythematosus ◽  
Cognitive Assessment ◽  
Memory Impairment ◽  
Montreal Cognitive Assessment ◽  
Systemic Lupus ◽  
Cross Sectional ◽  
Delayed Recall ◽  
Immediate Recall

Background: The involvement of neuropsychiatry is reported in 6% to 91% of Systemic Lupus Erythematosus (SLE) patients. It can cause fatal morbidity and mortality. Memory impairment is one of the most common symptoms of neuropsychiatry involvement. This study aims to find out the performance of memory test in SLE patients using Indonesian version of Montreal Cognitive Assessment (MoCA-Ina).Method: This cross sectional study recruited 30 SLE patients. Cognitive abilities and patient’s memory were examined using Indonesian version of Montreal Cognitive Assessment (MoCA-Ina). Cognitive impairment was determined when total MoCA-Ina score was below 26. For memory evaluation, immediate recall or delayed recall impairment was determined when the patient failed in each memory subtests.Results: The mean of total MoCA-Ina score was 24.97 (SD±3.14). Fifty percent of the SLE patients had cognitive impairment, with the domain involved being delayed recall (86.67%), attention (60%), language (56.67%), abstraction (53.33%), and visuo-spatial/ executive function (36.67%). Most patients (86.67%) could completely repeat immediate recall. Whileonly 4 (13.33%) subjects could repeat delayed recall completely without any clue. Of the 26 SLE patients who failed to recall completely, 24 (92.3%) of them succeeded to recall completely after getting clue(s).Conclusion: Memory impairment is the most frequent cognitive impairment in SLE patients, especially in delayed recall. By using the memory subtests of MoCAIna, more than four fifth of patients with SLE was detected having delayed recall memory impairment and almost all of them could recalled completely after getting clue(s). This findings indicated that the finalstep of memory process retrieval in SLE was interrupted while being encoded, but retention pathway were stillintact.Keywords: Systemic Lupus Erythematous, Memory, MoCA-Ina

scholarly journals Examining Delayed Recall in Cochlear Implant Users Using the Montreal Cognitive Assessment, California Verbal Learning Test, Third Edition, and Item Specific Deficit Approach: Preliminary Results

2021 ◽  
Vol 12 ◽  
Author(s):  
Nadav Brumer ◽  
Elizabeth Elkins ◽  
Jennifer Parada ◽  
Jake Hillyer ◽  
Alexandra Parbery-Clark
Keyword(s):  
Cochlear Implant ◽  
Cognitive Assessment ◽  
Recall Performance ◽  
Verbal Learning ◽  
Montreal Cognitive Assessment ◽  
California Verbal Learning Test ◽  
Scoring Method ◽  
Delayed Recall ◽  
High Performing ◽  
Learning Test

Purpose: Recent studies using the Montreal Cognitive Assessment (MoCA) suggest delayed recall is challenging for cochlear implant (CI) users. To better understand the underlying processes associated with delayed recall in CI users, we administered the MoCA and the California Verbal Learning Test, Third Edition (CVLT-3), which provides a more comprehensive assessment of delayed recall ability.Methods: The MoCA and CVLT-3 were administered to 18 high-performing CI users. For the CVLT-3, both the traditional scoring and a newer scoring method, the Item-Specific Deficit Approach (ISDA), were employed.Results: The original MoCA score and MoCA delayed recall subtest score did not relate to performance on any CVLT-3 measures regardless of scoring metric applied (i.e., traditional or ISDA). Encoding performance for both the CVLT-3 and ISDA were related. Consolidation, which is only distinctly defined by the ISDA, related to CVLT-3 cued delay recall performance but not free delay recall performance. Lastly, ISDA retrieval only related to CVLT-3 measures when modified.Conclusion: Performance on the MoCA and CVLT-3 in a high performing CI patient population were not related. We demonstrate that the ISDA can be successfully applied to CI users for the quantification and characterization of delayed recall ability; however, future work addressing lower performing CI users, and comparing to normal hearing controls is needed to determine the extent of potential translational applications. Our work also indicates that a modified ISDA retrieval score may be beneficial for evaluating CI users although additional work addressing the clinical relevance of this is still needed.

scholarly journals VALIDATION OF THE ALTERNATIVE BRAZILIAN VERSION OF THE MONTREAL COGNITIVE ASSESSMENT (MOCA-BR): PILOT STUDY

2021 ◽  
Author(s):  
Alana Pecorari ◽  
Viviane Zétola ◽  
Valmir Filho ◽  
Paulo Bertolucci ◽  
Carolina Ichi ◽  
...  
Keyword(s):  
Cognitive Assessment ◽  
Montreal Cognitive Assessment ◽  
Healthy Population ◽  
Delayed Recall ◽  
Brazilian Version ◽  
Significant Difference ◽  
Alternative Version ◽  
Good Internal Consistency ◽  
Crosscultural Adaptation ◽  
Prospective Longitudinal

Background: The current version of the Brazilian Montreal Cognitive Assessment (MoCA-BR) did not have a reliable cross-cultural adaptation to Brazil-ian Portuguese. In previous stages of this study, the Alternative Version of the MoCA-BR was developed, with changes in the sections: Memory and Delayed Recall, Language and Naming. Objectives: to verify the influence of crosscultural adaptation on the performance of cognitive tools, and the accuracy of the Alternative Version of the MoCA-BR. Methods: a pilot, prospective, longitudinal and analytical study. Both versions of the test were applied in a randomized and cognitively healthy population, between 18 and 60 years, within a medium interval of 54,56 days between the questionnaires. Results: out of 104 participants, 70 were included (64.3% female, 40.2 years). The alternative version obtained superior performances in the naming domain (p < 0.001), and in the adapted sentence in the language domain (p = 0.003). There was no significant difference in the delayed recall domain. The alternative version showed good internal consistency, with a Cronbach’s alpha of 0.75. The cutoff point suggested by the study is 27 points, with sensitivity and specificity of 91.3% and 79.2%, respectively. Conclusions: Cultural factors affect the accuracy of cognitive tests, and adaptation is essential for their use in different countries.

Utility of Montreal Cognitive Assessment in Differentiating Dementia With Lewy Bodies From Alzheimer’s Dementia

2017 ◽  
Vol 32 (8) ◽  
pp. 468-471 ◽  
Author(s):  
Erin Yamamoto ◽  
Lyla Mourany ◽  
Rosemary Colleran ◽  
Christine Whitman ◽  
Babak Tousi
Keyword(s):  
Executive Function ◽  
Cognitive Assessment ◽  
Dementia With Lewy Bodies ◽  
Lewy Bodies ◽  
Montreal Cognitive Assessment ◽  
Delayed Recall ◽  
Clock Drawing ◽  
Recall Memory ◽  
Score Pattern ◽  
Neurodegenerative Dementias

Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB) are the 2 most common neurodegenerative dementias. Identification of patients with DLB is necessary to guide appropriate clinical management and medication trials. Patients with DLB are reported to perform poorly on tasks of visuospatial and executive function, compared to patients with AD who perform poorly on memory tasks. Using the Montreal Cognitive Assessment, we found that patients with DLB (n = 73) had statistically significant lower performance in clock drawing (visuospatial and executive function) and higher performance in delayed recall (memory) subscores compared to patients with AD (n = 57). This score pattern should raise suspicion for a DLB diagnosis at initial evaluation of patients with dementia.

Validation of the Czech Montreal Cognitive Assessment for Mild Cognitive Impairment due to Alzheimer Disease and Czech Norms in 1,552 Elderly Persons

2018 ◽  
Vol 46 (5-6) ◽  
pp. 335-345 ◽  
Author(s):  
Ales Bartos ◽  
Dan Fayette
Keyword(s):  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Alzheimer Disease ◽  
Cognitive Assessment ◽  
Large Population ◽  
Montreal Cognitive Assessment ◽  
Cutoff Score ◽  
Elderly Persons ◽  
Delayed Recall ◽  
Delay Sensitivity

Background: The Czech version of the Montreal Cognitive Assessment (MoCA-CZ) and delayed recall of 5 words have not been validated in patients with mild cognitive impairment (MCI) due to Alzheimer disease (AD) and compared to norms of a large population. Method: The MoCA-CZ was administered to 1,600 elderly individuals in 2 groups consisting of 48 patients with MCI due to AD (AD-MCI) and 1,552 normal elderly adults. Results: MoCA-CZ scores were significantly lower in the AD-MCI patients than in the normal elderly (21 ± 4 vs. 26 ± 3 points; p = 0.03). Under the recommended cutoff score of ≤25, the MoCA-CZ demonstrated an excellent sensitivity of 94% but a low specificity of 62%. When the score was reduced to ≤24, the MoCA-CZ showed an optimal sensitivity of 87% for AD-MCI and a specificity of 72%. Normal elderly persons should recall at least 2 words after delay (sensitivity 80%, specificity 74%). Several cutoff points were derived from normative data stratified by age and education. Conclusions: The cutoff for AD-MCI and stratified norms are available for the MoCA total score and delayed recall of the Czech version. The cut-off scores of the MoCA-CZ, sensitivity, and specificity are lower than in the original study.

scholarly journals EFEKTIVITAS DONEPEZIL TERHADAP FUNGSI KOGNITIF PASIEN TUMOR INTRAKRANIAL PASCAOPERASI

2020 ◽  
Vol 37 (2) ◽  
Author(s):  
Yusril Harun ◽  
Yunni Diansari ◽  
Selly Marisdina ◽  
Yuli Felistia
Keyword(s):  
Cognitive Function ◽  
Mental State ◽  
Cognitive Assessment ◽  
Mini Mental State Examination ◽  
Montreal Cognitive Assessment ◽  
Double Blind Study ◽  
Intracranial Tumour ◽  
Delayed Recall ◽  
The Third ◽  
State Examination

EFFECTIVITY OF DONEPEZIL IN COGNITIVE FUNCTION OFPOSTOPERATIVE INTRACRANIAL TUMOUR PATIENTSABSTRACTIntroduction: There is still a lack of effective therapy in improving cognitive dysfunction in intracranial tumour patients after surgery. Donepezil is an acetylcholinesterase inhibitor that has been a therapy of Alzheimer's disease and has a significant effect on improving cognitive function.Aim: To determine the effectiveness of donepezil on cognitive function in patients with postoperative intracranial tumours.Methods: A clinical, randomized, double-blind study was conducted on postoperative intracranial tumour patients categorized into two groups (donepezil and placebo). The intervention was donepezil 5mg once a day for three months. For assessment of cognitive function, Mini-Mental State Examination (MMSE) and Indonesian Version of Montreal Cognitive Assessment (MoCA-Ina) was checked at weeks 0 (baseline), 4 (end of the first month), 8 (end of the second month), and 12 (end of the third month). Data were analyzed using SPSS 22.Results: Twenty patients, equally distributed in two groups, were included in the study. Compared to baseline, MMSE and MoCA-Ina scores in the donepezil group increased significantly on the second and third month (p<0.001). There was a remarkable difference in cognitive function between two groups on the third month based on MMSE and MoCA-Ina scores (p=0.027 and 0.024, respectively). At post-intervention, orientation and recalldomain in MMSE showed marked improvement, while visuospatial and delayed recall domain experienced as well in MoCA-Ina. There were no significant side effects of donepezil.Discussion: This results can be considered for administration of donepezil in patients with intracranial tumours after surgery with impaired cognitive function.Keywords: Cognitive function, donepezil, intracranial tumour, MMSE, MoCA-Ina, surgeryABSTRAKPendahuluan: Saat ini belum ada terapi yang efektif dalam memperbaiki gangguan fungsi kognitif pada pasien tumor intrakranial pascaoperasi. Donepezil merupakan inhibitor asetilkolinesterase yang telah menjadi terapi dari penyakit Alzheimer dan memiliki efek yang bermakna dalam memperbaiki fungsi kognitif.Tujuan: Mengetahui efektivitas donepezil terhadap fungsi kognitif pasien tumor intrakranial pascaoperasi.Metode: Studi uji klinis, acak, tersamar ganda dilakukan pada pasien tumor intrakranial pascaoperasi dengan gangguan kognitif yang terbagi dalam dua kelompok (donepezil dan plasebo). Intervensi yang dilakukan berupa pemberian donepezil 5mg satu kali sehari selama 3 bulan. Evaluasi fungsi kognitif menggunakan Mini Mental State Examination (MMSE) dan Montreal Cognitive Assessment Versi Indonesia (MoCA-Ina) pada minggu 0 (awal), 4 (akhir bulan ke-1), 8 (akhir bulan ke-2), dan 12 (akhir bulan ke-2). Data dianalisis menggunakan perangkat SPSS 22.Hasil: Sebanyak 20 subjek yang terbagi sama pada dua kelompok diikutsertakan pada penelitian ini. Dibandingkan dengan kondisi awal, nilai MMSE dan MoCA-Ina pada kelompok donepezil meningkat secara signifikan pada bulan ke-2 dan ke-3 (p<0,001). Terdapat perbedaan bermakna fungsi kognitif antara kelompok terapi dengan placebo pada bulan ke-3 berdasarkan nilai MMSE (p=0,027) dan MoCA-Ina (p=0,024). Domain pada MMSE yang mengalami perbaikan bermakna setelah terapi donepezil adalah orientasi dan recall, sedangkan pada MoCA-Ina adalah domain visuospasial dan delayed recall. Tidak didapatkan efek samping donepezil yang bermakna.Diskusi: Hasil penelitian ini dapat menjadi pertimbangan dalam pemberian donepezil pada pasien dengan tumor intrakranial pascaoperasi yang memiliki gangguan fungsi kognitif.Kata kunci: Donepezil, fungsi kognitif, MMSE, MoCA-Ina, operasi, tumor intrakranial

Montreal Cognitive Assessment--Filipino Version

2013 ◽  
Author(s):  
Jacqueline C. Dominguez ◽  
Mary Grace S. Orquiza ◽  
Jennifer R. Soriano ◽  
Cely D. Magpantay ◽  
Rolando C. Esteban ◽  
...  
Keyword(s):  
Cognitive Assessment ◽  
Montreal Cognitive Assessment

O2-04-01: Comparison of Montreal Cognitive Assessment (MoCA) and 3MSE scores in African-Americans

2013 ◽  
Vol 9 ◽  
pp. P321-P321
Author(s):  
Kaycee Sink ◽  
Suzanne Craft ◽  
Carrie Smith ◽  
Joseph Maldjian ◽  
Barry I. Freedman ◽  
...  
Keyword(s):  
African Americans ◽  
Cognitive Assessment ◽  
Montreal Cognitive Assessment

scholarly journals Concurrent validity of the short version of Montreal Cognitive Assessment (MoCA) for patients with stroke

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Yali Feng ◽  
Jiaqi Zhang ◽  
Yi Zhou ◽  
Bo Chen ◽  
Ying Yin
Keyword(s):  
Neurological Disorders ◽  
Cognitive Assessment ◽  
Concurrent Validity ◽  
Operating Characteristic ◽  
Cognitive Impairments ◽  
Characteristic Curve ◽  
Cognitive Status ◽  
Montreal Cognitive Assessment ◽  
Short Version ◽  
External Criterion

AbstractThe aim of the present study was to examine the concurrent validity of 2 Chinese versions of the short version of the Montreal Cognitive Assessment (MoCA) in patients with stroke, i.e., MoCA 5-minute protocol and National Institute for Neurological Disorders and Stroke and Canadian Stroke Network (NINDS-CSN) 5-minute Protocol. A total of 54 patients and 27 healthy controls were enrolled in this study. In this study, the Neurobehavioural Cognitive Status Examination (NCSE) was used as an external criterion of cognitive impairment. We found that the 5-min protocol did not differ from the MoCA in differentiating patients with cognitive impairments from those without (area under the receiver operating characteristic curve, AUC, of 0.948 for the MoCA 5-min protocol v.s. 0.984 for MoCA, P = 0.097). These three assessments demonstrated equal performance in differentiating patients with stroke from controls. The Chinese version of the MoCA 5-min protocol can be used as a valid screening for patients with stroke.

Sign in / Sign up

Export Citation Format

Share Document